chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Redness, induration at injection site, pain, fatigue and fever after receiving vaccination. KEFLEX rx'd for 10 day course of treatment.
Tiredness / Fatigue; Muscle pain; Chills; Fever; Diarrhea; Dizziness; I have lost some weight; I have been so ill; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 65-year-old female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: EN6200), via an unspecified route of administration on 22Feb2021 (at the age of 65-years-old) as dose 1, single (30 mcg per 0.3 ml) for COVID-19 immunisation. The medical history of the patient included hypertension and COVID. The concomitant medications of the patient were not reported. The patient experienced tiredness / fatigue, muscle pain, chills, fever, diarrhea, dizziness, i have lost some weight, i have been so ill on an unspecified date. The patient stated that she had been so ill. She did not told them that about 5 weeks ago she did actually have Covid, she do not know if that was the reason why she was having such a strong reaction to that vaccine. She did not  ttok treatment because she was told that they should let the body take care of that response. So, she did not even take any kind of fever meds or anything. The patient underwent lab tests and procedures which included body temperature: 102 on and weight: i am about 197 pounds both on unspecified date. The outcome of the events was reported as unknown.  No follow up attempts are possible. No further information is expected.
entire arm above elbos is again so red; so sick that evening; dry heaves; feverish; didn't eat well; I was feeling weak; very itchy; was just in bed all day next day; Dark bruise appeared; week later, lump 4 inches lower than the injection site; A spontaneous report was received from a healthcare professional concerning a 88-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events arm was sore for couple days, week later, lump 4 inches lower than the injection site, a reaction, dark bruise appeared, whole arm above the elbow was all red, itchy, bruise got quite huge, took a week to go away, entire arm above elbow is again so red, very itchy, so sick that evening, dry heaves, feverish, was just in bed all day next day, didn't eat well, i was feeling weak.  The patient's medical history was not provided. Concomitant medications reported were Baby aspirin, Levothyroxine for drug use for unknown indication.  On 28 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: Lot# 030L20A) via unknown route in the left arm for prophylaxis of COVID-19 infection. On 26 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: Lot# 011A21A) via unknown route in the left arm for prophylaxis of COVID-19 infection.  On 28 Jan 2021, the patient experienced the event(s) arm was sore for couple days. On 4 Feb 2021, the patient experienced the event(s) week later, lump 4 inches lower than the injection site, a reaction, dark bruise appeared, whole arm above the elbow was all red, itchy, bruise got quite huge, took a week to go away. On 26 Feb 2021, the patient experienced the event(s) entire arm above elbow is again so red, very itchy, so sick that evening, dry heaves, feverish, was just in bed all day next day, didn't eat well, i was feeling weak.  Treatment details included n a.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), arm was sore for couple days, week later, lump 4 inches lower than the injection site, a reaction, dark bruise appeared, whole arm above the elbow was all red, itchy, bruise got quite huge, took a week to go away, entire arm above elbow is again so red, very itchy, so sick that evening, dry heaves, feverish was just in bed all day next day, didn't eat well, i was feeling weak was unknown.
Hives; This is a spontaneous report from a contactable Other Health Professional (patient). A 27-Year-old female patient received second dose of BNT162B2 (COMIRNATY, Solution for injection, Lot number EL3247) via unspecified route of administration at arm left on 27Jan2021 at 09:00 AM as single dose for COVID-19 immunization. Medical history included allergies to sulfa antibiotics. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication was not reported. Previously patient received first dose of BNT162B2 for COVID-19 immunization. On an unknown date, patient experienced hives. No COVID prior vaccination. Patient has not tested COVID-19 post vaccination. The outcome of event was unknown.  Follow-up attempts are completed. No further information is expected.
COVID-19 Vaccine - Johnson & Johnson "Janssen"  Lot Number - 18222811  0  The vaccine was administered on my right Deltoid muscle on  Monday, October 25, 2021 at approximately 11:30 am.  Three days later on October 28, 2021 at 7:40 am there is a noticeable painful enlarged lymph node located on the upper right collar bone.
Undifferentiated pleomorphic Sarcoma left shoulder Deltoid. Starting Radiation therapy + surgical excision planned Mass started in July 2021?
she has an itchy rash; BOOSTER; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a sponsored program.  A 75-year-old female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) at the age of 75 years as dose 3 (booster), single for covid-19 immunisation; influenza vaccine (FLU VACCINE) (Batch/Lot number: unknown). Relevant medical history included: "Rheumatoid arthritis" (ongoing); "Psoriasis" (ongoing). The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, MANUFACTUERER UNKNOWN), for COVID-19 immunisation; Covid-19 vaccine (DOSE 2, MANUFACTUERER UNKNOWN), for COVID-19 immunisation. The following information was reported: RASH PRURITIC (non-serious) with onset 2021, outcome "unknown", described as "she has an itchy rash"; IMMUNISATION (non-serious) with onset 2021, outcome "unknown", described as "BOOSTER". The action taken for influenza vaccine was unknown.  Additional information: The patient stated that she had an itchy rash that she received after her flu shot and her covid vaccine booster. Action taken with Enbrel with Reusable Autoinjector was reported as unknown for the event rash pruritic. The causal relationship between the event rash pruritic and Enbrel, Reusable Autoinjector was not provided by the consumer. The reporter declined consent to contact.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
tiredness/exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tiredness/exhaustion) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 31M20A.) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 28-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (tiredness/exhaustion). At the time of the report, FATIGUE (tiredness/exhaustion) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.
I contracted Covid 19 in mid October 2020 and I lost my sense of smell and taste.  It took a long time to start coming back and was at about 60% of normal when I received the 2nd dose of the Pfizer vaccine.  Four days after the shot my sense of smell and taste changed.  From that day until present almost everything I smell and taste has a "chemical" taste and smell.  Nothing smells normal and very few things taste good.  Animal proteins are especially bad as well as some fruits and vegetables.  Most foods make my stomach so upset that it is nearly impossible to eat.  All smells are the same, nothing smells pleasant and most smells give me a light headache.  I have lost over ten pounds since this started and I have general malaise.
Seizures, HA, muscle and joint aches, fatigue that developed after anthrax vaccination.
5 MINUTES AFTER VACCINE WAS ADMINISTRED, PATINET STARTED COMPLAINING OF FEELING LITTLE DIZZY AND NOT ABLE TO SEE AT ALL FOR 10 MINUTES.PT WAS HOT TO TOUCH.
12 hours after vaccine I got fever, body ache, this time I got swelling in my fingers, feet and hands, for 5 days I have terrible headache and fever, no higher than 101. As the weeks went by, I got rash on my head, forehead and my eyes. I will see the doctor on August 30th, 2022.
Immediately, I had increased  heart rate - 194 - I fainted to the ground. I became nauseous, sick and had seizure like episode and then I had tingling sensation in my face and limbs. They gave me shot epi-pen - two doses. I was pretty much paralyzed for hands and legs. I was brought to hospital and they treated me there for about a week and I had muscle weakness. I gained feeling back in my hands but not in my feet. I was at Haywood for a week. Outpatient therapy and a visiting nurse for three weeks. B12; Iron; Gabapentin and that was for anxiety through it all.  Test results came up as neuropathy on left side of my body. I have pins and needles pain now. I did gain my walking back. I take Gabapentin for neuropathy pain. I went to hospital - went one day and I didn't get anything back from them.  I now use handicap parking for disability.
Pt had a fever from vaccines, (she always gets one). She had a febrile seizure that lasted for 1 1/2 hours. She was life-lined to the hospital. They did not give us a recovery date. She did not recover.60 day follow-up states the pt has neurological deficites that consist of delays in congnition, motor and language skills and needs assistance with self help skills.
Extremely severe arm pain with injection and pain after (more than any of my 4 COVID vaccines) and more than the first Shingrix vaccine.. Arm pain persisted for the next few days but has been improving. About 30 hours after the injection site became hot, indurated, and extremely tender (to the point of  a concern for a cellulitis or myositis)..  Took ibuprofen and acetaminophen and this has mostly resolved by day 4. Fatigue started the fisrt  day after injection. On the 3rd day after injection, a pharyngitis has begun and is ongoing .  Treating with acetaminophen. No axillary lymph nodes were associated with the arm and may have slight submandibular lymph nodes.  Symptoms ongoing today, day 4 post injection.
This spontaneous report was received from a registered nurse regarding multiple, unspecified patients of unknown demographics. There was no information about concurrent condition. On an unknown date the patients were vaccinated with improperly stored PROQUAD (Merck) lot # L005293, expiration date- 17-AUG-2016, lot # L014401, expiration date- 23-OCT-2016 and lot # L024122, expiration date- 30-DEC-2016. No adverse event was reported. The outcome of the event was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
The patient developed dizziness and progressed towards syncope upon standing from a seated position about 5 to 10 minutes post vaccination. There was no loss of consciousness and he was able to be guided to the ground so he would not fall. He was given a glass of water and I recommended he continue sitting at the pharmacy for 20 more minutes. After this time period he said he "felt better" and was able to comfortably walk away from the pharmacy without return of symptoms.
Employee  presented to the Emergency Department for dizziness.  Patient received COVID-19 vaccination today.  About an hour and half later he started experiencing dizziness and lightheadedness.  Patient was normotensive with regular heart rate at the time.  Patient reports when he would get up to go patient room he would start to feel unsteady.  Patient has history of orthostatic hypotension intermittently in the past.  Patient reports he had some tingling to his bilateral hands.
Patient fainted about 5 minutes after vaccination.  Did not hit head.  Regained consciousness in about 30 seconds.  He reported fainting with prior injections. Patient refused emergency care when they arrived due to cost.
Patient received monovalent Pfizer instead of bivalent Pfizer. No adverse side effects occured.
Patient is a 59 y.o. male patient of a MD with history of hypertension, hyperlipidemia, seizures, schizophrenia presented to a local Hospital with shortness of breath.  Patient lives in nursing home and was found to be 66% on room air.  Patient does not wear oxygen at home.  While in the ER patient was febrile with fever of 103.2 °F, lactate was elevated to 4.1.  Patient was placed on 4 L nasal cannula with improvement in oxygenation.  Patient tested positive for COVID-19 and is admitted for further evaluation and management.   COVID-19 infection COVID-19 pneumonia Acute on chronic respiratory failure Started patient on Decadron and remdesivir Patient is vaccinated Weaned  3 L nasal cannula patient is down to room air ID consult Status post discontinuation of IV vancomycin S/p IV remdesivir and dexamethasone Out of bed when possible   UTI not due to indwelling chronic catheter Urine culture showing Pseudomonas and providencia susceptible to Zosyn Severe sepsis 2/2 above E. coli bacteremia Patient has chronic Foley Continue IV Zosyn. Blood cultures E. coli on 618 repeat blood cultures on 621 no growth  Urine culture grew Pseudomonas and providencia ID is on board We will discharge on IV Zosyn for 14 days Mild AKI resolved Improved with IV fluids.  Creatinine back to 0.75   Elevated troponin Acute myocarditis Patient EKG was concerning for some ST changes Reviewed by cardiology, no acute intervention is planned Echocardiogram reviewed showed EF 74% with normal diastolic function Continue to trend troponin. Start patient on aspirin, continue home statin   Hypernatremia resolved   Hypertension Holding lisinopril due to sepsis and septic shock Resume on discharge   Partial idiopathic epilepsy with seizures Continue home medications including Keppra 500 mg twice daily, Dilantin 100 mg 3 times daily, phenobarbital 64.8 mg daily Follows with Dr. as outpatient.   Schizophrenia: Continue Haldol
24 hrs after receiving the 2nd dose I began experiencing severe itching of my hands and feet. This is still continuing three days later
Pain at injection site; Chills; Fever; Fatigue; Headache; This is a spontaneous report from a contactable nurse (patient herself).  This 44-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EJ1685), via an unspecified route, on 26Dec2020 (at 02:30 PM) at single dose for COVID-19 immunisation. Vaccine location was right arm. The patient was not pregnant. Relevant medical history included depression, endometriosis, and COVID-19 in Aug2020. The patient did not have relevant concomitant medications. No other vaccine was received in four weeks. No known allergies. No congenital anomaly/birth defect. The patient was vaccinated at hospital, age at vaccination was 44-year-old. On 27Dec2020 (at 02:00 AM) the patient woke up with chills, fever, fatigue, headache and fever 99.5. After taking 2 paracetamol (TYLENOL) (1.5hr after med temp was taken), she felt like it did when she had COVID in Aug2020. She also had pain at injection site as well (onset date not provided). Post-vaccination COVID test was not performed. Therapeutic measures were taken for fever, no treatments were given for chills, fatigue and headache. The patient had not recovered from fever, chills, fatigue and headache while the outcome from pain at injection site was unknown.
Information has been received from a licensed vocational nurse concerning a 71 year old male with non insulin dependent diabetes and elevated cholesterol who on 3/13/06 was vaccinated IM, into the left arm, with a 0.5 ml dose of Pneumococcal 23v polysaccharide vaccine (lot 649697/1038P). Concomitant therapy included Lovastatin. On 3/13/06, 7 hours after the vaccination, the pt developed severe nausea, vomiting, chills and redness, swelling and warmth at the injection site. Unspecified medical attention was sought. At the time of the report, the pt was recovering. Additional information has been requested.
Itching, swollen eye lids, chest tightness, body aches, fatigue. Treatment was antihistamines, rest, hydration, and tylenol. Symptoms persisting at about 48 hours post vaccine
My right arm is where I had the 2nd shot administered (used Left arm for dose #1).  I had my shot at 1:30pm on 4/12/21 and noticed sore arm pain throughout the day.  Tuesday 4/13/21 at 9am my entire body began to ache and was sensitive to touch and I was tired.   Tuesday evening at 10pm 4/13/21 my right armpit began to ache.  The aching remained all night and all day into Wednesday 4/14/21.  I can feel a lump (assuming lymph node) under my armpit.  It has become more painful to move as the day goes on.  I have also had some tingling in my right arm and lower back pain.
Information has been received from a physician's assistant (P.A.) concerning a 13-year-old male with no pertinent medical history or allergies, who on 22-JUL-1999 was vaccinated with a first dose of Varivax. there was no concomitant medication. On 07-AUG-2006 the patient had a titer taken and had a "failure to convert". The titer was less than 0.91 for IgG and the IgM was less than 0.90. Unspecified medical attention was sought. At the time of this report, the patient had not recovered and there was no further information. No product quality complaint was involved. The patient's brother also experienced "failure to convert" (WAES# 0608USA03682). Additional information is not expected.
Patient received Varicella vaccine SC RTR on 8/10/11 with no adverse reactions. Patient returned today 8/12/11 with a rash/reaction at the site of administration. Patient denies any other complaints/reactions. Dr treating patient with BENADRYL 25mg bid OTC.
This case was reported by a physician via call center representative and described the occurrence of therapy non-responder in a patient who received ENGERIX B. On an unknown date, the patient received ENGERIX B at an unknown dose. On an unknown date, unknown after receiving ENGERIX B, the patient experienced therapy non-responder. On an unknown date, the outcome of the therapy non-responder was unknown. It was unknown if the reporter considered the therapy non-responder to be related to ENGERIX B. Additional details were provided as follows: The age at the vaccination was not reported. The healthcare professional reported that no immunity established after receiving ENGERIX B, which led the patient to be a therapy non responder. No further details were provided by the healthcare professional and then disconnected the call.
20AUG91 11PM both legs minimal swelling, fever 100 AX; 21AUG91 couldn't walk for 2 hrs; p/getting up in AM, "cranky", fever 99.8-102.7 AX; mom noted small "knot" behind lt ear; 23AUG91 Seen by MD told "swollen lymph nodes" due to immun;
Within a minute after clinical staff administered the vaccines, patients mom came out of room to notify staff that patient developed a rash. The rash/hives were head to toe and his breathing was checked. The CNP was notified right away and she assessed him. patient received Benadryl and was continued to be monitered and breathing was assessed every 10-15 minutes for a good 45 minutes. Rash/hives started to slowly go away but both thighs were bright red and warm to touch. Patient never seemed in distress
Hospitalized due to a fall and found to have COVID on admission. Treatment includes monitoring during admission.
Fever of 101-102; Sore arm; This case was reported by a other health professional via sales rep and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced fever and pain in arm. On an unknown date, the outcome of the fever and pain in arm were unknown.   It was unknown if the reporter considered the fever and pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication.  After vaccination, the patient had fever of 101-102 degree Fahrenheit and very sore arm. This was 1 of the 10 cases reported by same reporter.       Lab Comments: Lab test performed on an unknown date.
Information has been received from a registered nurse referring to an unspecified number of patients of unknown age and gender. On unknown dates doses of improperly stored ROTATEQ (oral, dose, lot# were not reported) were administered to these patients. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several cases reported by the same reporter. Additional information has been requested.
Nurse injected me avoid the deltoid muscle.  She injected me in the shoulder capsule. I could not lift my arm for the first 4 days.  Now I have clicking and swelling in my left shoulder joint when I use it.
Felt sharp pain in right foot. Vein swollen and agitated. Went to ER. Diagnosed with superficial thrombophlebitis. Prescribed aspirin and hot/cold therapy/elevation
fatigue ,  dry cough ,  overall body aches ,  chills ,  headache
Patient experienced severe chills/shaking approximately 5 hours after the vaccine in 2014.
expired vaccine give. Expiration date of 5/18/23. Vaccine given on 6/30/23
Pfizer Dose 1 6/24/21 (lot NA) Pfizer Dose 2 7/16/21 (lot NA) COVID Positive 1/16/22 COVID Positive 1/18/22  1/18/22: 65-year-old lady who presented to the emergency room with a history of generalized fatigue and palpitation following infusion of antibody for the treatment of COVID.  The patient was diagnosed with COVID 2 days ago on Sunday, 01/16/2022, and was scheduled to get her antibody infusion today.  After the infusion, the patient was noted to have some episode of heart racing, complaining of fatigue.  She was sent to the emergency room for further evaluation.  In the emergency room, she was noted to be tachycardic up to 150.  She did not, however, desaturate.  The patient had a CT of the chest done that shows bilateral pulmonary embolism. Currently, she denies chest pain and denied nausea.  1/21/22: 65-year-old woman who presented complaints of chest discomfort and shortness of breath immediately following monoclonal and antibody infusion for recently diagnosed COVID-19 infection.  She was brought to the emergency department where she was found to be in atrial flutter.  Neatly on CT pulmonary angio angiogram revealed saddle  pulmonary embolism with areas of right middle and lower lobe infarcts.  She was admitted to the hospitalist Service, underwent transthoracic echocardiogram with no evidence of right ventricular strain.  Therapeutic anticoagulation was started with IV heparin and continued for 72 hours before being transition to oral Eliquis for anticoagulation.  Hospital course was remarkable for brief episode of scant hemoptysis and pleurisy which resolved prior to discharge.  No further episodes of arrhythmias were noted during hospital course.  She is in stable medical condition at the time of discharge.
On 11/07/2001 pt woke up 4 AM with temp 104.6, took antipyretic, stayed in bed all day, felt bad and ached all over. Face swollen, no difficulty breathing, stayed in bed. Thursday temp of 100 F. Still had joint pain with movement. No seizure activity.